Brain Tumor Treatment Satisfaction Survey

April 4, 2022 updated by: Methodist Healthcare

Treatment Satisfaction Survey for Brain Tumor Patients and Their Caregivers

Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state since receiving treatment.

Study Overview

Status

Completed

Conditions

Detailed Description

Patients with a recent diagnosis and treatment of a brain tumor (primary or metastatic; N=105, 61% female, 39% male) were identified in the clinics of Semmes-Murphey Neurologic and Spine Institute or the Methodist University Hospital in Memphis, TN. Caregivers were recruited from among relatives and friends who provide the most day-to-day care to the patient. All participants were between 3 months and 1 year from their most recent brain tumor treatment. Participants were given a simple, 5-point based survey to asses treatment-specific satisfaction, patient education, posttreatment quality of life, and pre- and post-treatment emotional impact. Therapeutic modalities surveyed include: surgery, external beam radiotherapy, whole-brain radiotherapy, stereotactic radiosurgery, and chemotherapy.

Study Type

Observational

Enrollment (Actual)

105

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Tennessee
      • Memphis, Tennessee, United States, 38104
        • Methodist University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Brain tumor patients and their caregivers

Description

Inclusion Criteria:

  • Patients who are between 3 months and one year out from treatment for their brain tumor
  • Karnofsky Performance Status (KPS) >= 60
  • Age 18 years or over, any gender, any race
  • "patient caregivers will be individuals who provide the most day-to-day care for their respective brain tumor patients

Exclusion Criteria:

  • No exclusions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
1
Brain tumor patients
2
Caregivers of brain tumor patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Overall satisfaction and emotional impact of treatments in patients who have undergone therapy(s)for brain tumors.
Time Frame: (greater than or equal to 3 months) from first treatment for brain tumor
(greater than or equal to 3 months) from first treatment for brain tumor

Secondary Outcome Measures

Outcome Measure
Time Frame
Observational data about the treatment course and emotional well-being of the brain tumor patient as provided by the caregiver.
Time Frame: (Greater than or equal to 3 months) from first treatment for brain tumor
(Greater than or equal to 3 months) from first treatment for brain tumor

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Methodist Healthcare

Investigators

  • Principal Investigator: Jeffrey M. Sorenson, MD, Methodist Healthcare

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2007

Primary Completion (Actual)

March 1, 2009

Study Completion (Actual)

March 1, 2009

Study Registration Dates

First Submitted

November 13, 2007

First Submitted That Met QC Criteria

November 13, 2007

First Posted (Estimate)

November 14, 2007

Study Record Updates

Last Update Posted (Actual)

April 11, 2022

Last Update Submitted That Met QC Criteria

April 4, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MHIRB 2007-036

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Brain Tumors

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe